HomeCompareCRPOF vs PLD

CRPOF vs PLD: Dividend Comparison 2026

CRPOF yields 1176.47% · PLD yields 3.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CRPOF wins by $78814189.29M in total portfolio value
10 years
CRPOF
CRPOF
● Live price
1176.47%
Share price
$0.17
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$78814195.20M
Annual income
$67,523,701,253,088.38
Full CRPOF calculator →
PLD
PLD
● Live price
3.10%
Share price
$132.18
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.91M
Annual income
$4,750,725.19
Full PLD calculator →

Portfolio growth — CRPOF vs PLD

📍 CRPOF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCRPOFPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CRPOF + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CRPOF pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CRPOF
Annual income on $10K today (after 15% tax)
$100,000.00/yr
After 10yr DRIP, annual income (after tax)
$57,395,146,065,125.13/yr
PLD
Annual income on $10K today (after 15% tax)
$263.66/yr
After 10yr DRIP, annual income (after tax)
$4,038,116.41/yr
At 15% tax rate, CRPOF beats the other by $57,395,142,027,008.71/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CRPOF + PLD for your $10,000?

CRPOF: 50%PLD: 50%
100% PLD50/50100% CRPOF
Portfolio after 10yr
$39407100.55M
Annual income
$33,761,853,001,906.78/yr
Blended yield
85.67%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

CRPOF
No analyst data
Altman Z
3.3
Piotroski
2/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+2.9% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CRPOF buys
0
PLD buys
0
No recent congressional trades found for CRPOF or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCRPOFPLD
Forward yield1176.47%3.10%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$78814195.20M$5.91M
Annual income after 10y$67,523,701,253,088.38$4,750,725.19
Total dividends collected$77969765.27M$5.78M
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: CRPOF vs PLD ($10,000, DRIP)

YearCRPOF PortfolioCRPOF Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$128,347$117,647.06$11,241$540.96+$117.1KCRPOF
2$1,548,514$1,411,182.61$13,019$991.13+$1.54MCRPOF
3$17,569,052$15,912,142.01$15,801$1,870.97+$17.55MCRPOF
4$187,523,354$168,724,468.35$20,609$3,701.21+$187.50MCRPOF
5$1,883,716,681$1,683,066,692.55$29,919$7,867.97+$1883.69MCRPOF
6$17,816,329,317$15,800,752,468.33$50,631$18,617.74+$17816.28MCRPOF
7$158,731,384,105$139,667,911,735.60$105,528$51,352.20+$158731.28MCRPOF
8$1,332,782,916,056$1,162,940,335,063.89$287,364$174,449.42+$1332782.63MCRPOF
9$10,551,863,503,163$9,125,785,782,982.70$1,081,760$774,280.77+$10551862.42MCRPOF
10$78,814,195,201,473$67,523,701,253,088.38$5,908,209$4,750,725.19+$78814189.29MCRPOF

CRPOF vs PLD: Complete Analysis 2026

CRPOFStock

Ceapro Inc., a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. It operates in two segments, Active Ingredient Product Technology Industry and Cosmeceutical Industry. The Active Ingredient Product Technology Industry segment develops proprietary extraction technologies and the application of these technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries. The Cosmeceutical Industry segment is involved in the development and commercialization of anti-aging products derived from natural active ingredients sold directly to the end-user primarily through online website sales and through select natural products stores. The company was incorporated in 1997 and is headquartered in Edmonton, Canada.

Full CRPOF Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this CRPOF vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CRPOF vs SCHDCRPOF vs JEPICRPOF vs OCRPOF vs KOCRPOF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.